ICD-10 Coding for Sclerosing Adenosis of the Left Breast(N60.82)
Complete ICD-10-CM coding and documentation guide for Sclerosing Adenosis of the Left Breast. Includes clinical validation requirements, documentation requirements, and coding pitfalls.
Also known as:
Related ICD-10 Code Ranges
Complete code families applicable to Sclerosing Adenosis of the Left Breast
N60-N64Primary Range
Benign Mammary Dysplasias
This range includes codes for benign breast conditions, including sclerosing adenosis.
Key Information: ICD-10 code for sclerosing adenosis left breast
Essential facts and insights about Sclerosing Adenosis of the Left Breast
Primary ICD-10-CM Code for sclerosing adenosis left breast
Decision Criteria
clinical Criteria
- Biopsy confirms sclerosing adenosis without atypia.
Applicable To
- Sclerosing adenosis of the left breast
Excludes
- Malignant neoplasm of breast (C50.-)
Clinical Validation Requirements
- Biopsy confirmation of sclerosing adenosis
- Imaging findings consistent with benign changes
Code-Specific Risks
- Misclassification as malignant neoplasm
Coding Notes
- Ensure laterality is specified as left breast.
Ancillary Codes
Additional codes that should be used in conjunction with the main diagnosis codes when applicable.
Inconclusive mammogram
R92.2Differential Codes
Alternative codes to consider when ruling out similar conditions to the primary diagnosis.
Malignant neoplasm of left breast
C50.912Documentation & Coding Risks
Avoid these common documentation and coding issues when documenting Sclerosing Adenosis of the Left Breast to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code N60.82.
Impact
Clinical: May lead to confusion in treatment planning., Regulatory: Non-compliance with coding standards., Financial: Potential for denied claims.
Mitigation Strategy
Always document the side of the breast affected., Use templates that prompt for laterality.
Impact
Reimbursement: Incorrect coding may lead to inappropriate DRG assignment., Compliance: Misclassification can result in audit issues., Data Quality: Affects accuracy of clinical data.
Mitigation Strategy
Ensure biopsy confirms benign nature before coding.
Impact
Failure to specify laterality can lead to audit findings.
Mitigation Strategy
Implement documentation checks to ensure laterality is recorded.
Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.
Frequently Asked Questions
Common questions about ICD-10 coding for Sclerosing Adenosis of the Left Breast, with expert answers to help guide accurate code selection and documentation.
Documentation Templates for Sclerosing Adenosis of the Left Breast
Use these documentation templates to ensure complete and accurate documentation for Sclerosing Adenosis of the Left Breast. These templates include all required elements for proper coding and billing.
Biopsy-confirmed sclerosing adenosis
Specialty: PathologyRequired Elements
- Histological findings
- Presence of myoepithelial cells
- Absence of malignancy
Example Documentation
Examples: Poor vs. Good Documentation
Poor Documentation Example
Good Documentation Example
Explanation
Need help with ICD-10 coding for Sclerosing Adenosis of the Left Breast? Ask your questions below.